United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05(BR:U2TH34)
R$164.640.00 (0.00%)
BR:U2TH34
United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05 earnings date
R$164.64
At close:0.00 (0.00%)
United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05 (U2TH34) Q2 2024 Earnings Report
BR:U2TH34 Q2 2024 EPS Results
- Actual EPS
- BRL 0.00
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- BRL 0.00
BR:U2TH34 Q2 2024 Revenue Results
- Actual Revenue
- BRL 3.72B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +26.01%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 07/31/2024
- Time
- Before Open
- Conference Call
- Wednesday, July 31, 2024
BR:U2TH34 Upcoming Earnings
United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
BR:U2TH34 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | ―- | 0 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | ―0.00 | 0 | -50.00% (-0.00) | |
| Aug 05, 2026 | 2026 (Q2) | ―0.00 | 0 | 0.00% (+0.00) | |
| May 06, 2026 | 2026 (Q1) | ―0.00 | 0 | 0.00% (+0.00) | |
| Feb 25, 2026 | 2025 (Q4) | ―0.00 | 0 | 0.00% (+0.00) | |
| Oct 29, 2025 | 2025 (Q3) | ―0.00 | 0 | 0.00% (+0.00) | |
| Jul 30, 2025 | 2025 (Q2) | ―0.00 | 0 | 0.00% (+0.00) | |
| Apr 30, 2025 | 2025 (Q1) | ―0.00 | 0 | 0.00% (+0.00) | |
| Feb 26, 2025 | 2024 (Q4) | ―0.00 | 0 | 100.00% (+0.00) | |
| Oct 30, 2024 | 2024 (Q3) | ―0.00 | 0 | 100.00% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

